293 related articles for article (PubMed ID: 12070288)
1. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.
Scheu S; Alferink J; Pötzel T; Barchet W; Kalinke U; Pfeffer K
J Exp Med; 2002 Jun; 195(12):1613-24. PubMed ID: 12070288
[TBL] [Abstract][Full Text] [Related]
2. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
[TBL] [Abstract][Full Text] [Related]
3. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
[TBL] [Abstract][Full Text] [Related]
4. Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo.
Abe K; Yarovinsky FO; Murakami T; Shakhov AN; Tumanov AV; Ito D; Drutskaya LN; Pfeffer K; Kuprash DV; Komschlies KL; Nedospasov SA
Blood; 2003 Feb; 101(4):1477-83. PubMed ID: 12560241
[TBL] [Abstract][Full Text] [Related]
5. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator.
Mauri DN; Ebner R; Montgomery RI; Kochel KD; Cheung TC; Yu GL; Ruben S; Murphy M; Eisenberg RJ; Cohen GH; Spear PG; Ware CF
Immunity; 1998 Jan; 8(1):21-30. PubMed ID: 9462508
[TBL] [Abstract][Full Text] [Related]
6. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
[TBL] [Abstract][Full Text] [Related]
7. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.
Endres R; Alimzhanov MB; Plitz T; Fütterer A; Kosco-Vilbois MH; Nedospasov SA; Rajewsky K; Pfeffer K
J Exp Med; 1999 Jan; 189(1):159-68. PubMed ID: 9874572
[TBL] [Abstract][Full Text] [Related]
8. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.
Alimzhanov MB; Kuprash DV; Kosco-Vilbois MH; Luz A; Turetskaya RL; Tarakhovsky A; Rajewsky K; Nedospasov SA; Pfeffer K
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9302-7. PubMed ID: 9256477
[TBL] [Abstract][Full Text] [Related]
9. The lymphotoxin pathway: beyond lymph node development.
McCarthy DD; Summers-Deluca L; Vu F; Chiu S; Gao Y; Gommerman JL
Immunol Res; 2006; 35(1-2):41-54. PubMed ID: 17003508
[TBL] [Abstract][Full Text] [Related]
10. Recombinant, soluble LIGHT (HVEM ligand) induces increased IL-8 secretion and growth arrest in A375 melanoma cells.
Hehlgans T; Männel DN
J Interferon Cytokine Res; 2001 May; 21(5):333-8. PubMed ID: 11429164
[TBL] [Abstract][Full Text] [Related]
11. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
[TBL] [Abstract][Full Text] [Related]
12. Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos.
Browning JL; French LE
J Immunol; 2002 May; 168(10):5079-87. PubMed ID: 11994460
[TBL] [Abstract][Full Text] [Related]
13. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin beta.
Koni PA; Flavell RA
J Exp Med; 1998 Jun; 187(12):1977-83. PubMed ID: 9625757
[TBL] [Abstract][Full Text] [Related]
14. Lymphotoxin-beta receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells.
Stopfer P; Männel DN; Hehlgans T
J Immunol; 2004 Jun; 172(12):7459-65. PubMed ID: 15187124
[TBL] [Abstract][Full Text] [Related]
15. Lymphotoxin-beta-deficient mice show defective antiviral immunity.
Berger DP; Naniche D; Crowley MT; Koni PA; Flavell RA; Oldstone MB
Virology; 1999 Jul; 260(1):136-47. PubMed ID: 10405365
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: selective impairment of CD8+ T cell function in mice lacking the TNF superfamily member LIGHT.
Tamada K; Ni J; Zhu G; Fiscella M; Teng B; van Deursen JM; Chen L
J Immunol; 2002 May; 168(10):4832-5. PubMed ID: 11994431
[TBL] [Abstract][Full Text] [Related]
17. Intestinal cryptopatch formation in mice requires lymphotoxin alpha and the lymphotoxin beta receptor.
Taylor RT; Lügering A; Newell KA; Williams IR
J Immunol; 2004 Dec; 173(12):7183-9. PubMed ID: 15585839
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells.
del Rio ML; Fernandez-Renedo C; Chaloin O; Scheu S; Pfeffer K; Shintani Y; Perez-Simon JA; Schneider P; Rodriguez-Barbosa JI
MAbs; 2016; 8(3):478-90. PubMed ID: 26752542
[TBL] [Abstract][Full Text] [Related]
19. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection.
Roach DR; Briscoe H; Saunders B; France MP; Riminton S; Britton WJ
J Exp Med; 2001 Jan; 193(2):239-46. PubMed ID: 11208864
[TBL] [Abstract][Full Text] [Related]
20. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.
Rennert PD; Browning JL; Hochman PS
Int Immunol; 1997 Nov; 9(11):1627-39. PubMed ID: 9418124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
